Methods for targeted cleavage and recombination of CCR5

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8349810
APP PUB NO 20120014928A1
SERIAL NO

13165866

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are methods and compositions for targeted cleavage of a genomic sequence, targeted alteration of a genomic sequence, and targeted recombination between a genomic region and an exogenous polynucleotide homologous to the genomic region. The compositions include fusion proteins comprising a cleavage domain (or cleavage half-domain) and an engineered zinc finger domain, as well as polynucleotides encoding same. Fusion proteins comprising cleavage half-domains are used in pairs to reconstitute a functional cleavage domain. In these fusion proteins, the zinc finger domain can be N-terminal to the cleavage half-domain, or the cleavage half-domain can be N-terminal to the zinc finger domain. The availability of fusion endonucleases having these different polarities allows targeting of zinc finger endonucleases either to opposite strands of the DNA target or to the same strand of the DNA target, thereby increasing the number of possible sequences which can be targeted and cleaved by the fusion proteins.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANGAMO THERAPEUTICS INC7000 MARINA BOULEVARD BRISBANE CA 94005

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Miller, Jeffrey C San Francisco, US 104 3965
Zhang, Lei Davis, US 2799 20393

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation